Sixth Dissolving ADHD Tablet Approved for Kids

Neos Therapeutics announces this week the recent approval of its pediatric ADHD medication, Cotempla. The medication is approved for use in children ages 6-17 years old. The tablet is an extended-release product which dissolves in the mouth, making regular use easier...

Anthem to Begin Wisconsin, Indiana Obamacare Exit

Anthem has announced plans to reduce the amount of individual plans it offers in Wisconsin and Indiana. The insurer’s plans to exit the Affordable Care Act in these states is cited as a result of legislative uncertainty and a lack of cost sharing reductions from the...

Iowa Introduces Bill to Remove Insurers from Obamacare Exchange

Iowa state representatives announced a healthcare plan this week to reduce the amount of insurers on the healthcare exchange. Iowa Insurance Commissioner, Doug Ommen, met with insurers and officials from the Center for Medicare and Medicaid Services in Washington to...

Myomo Launches Powered Arm Brace for Paralyzed and Weakened Limbs

Myomo, a commercial stage medical robotics company, announced this week the launch of its next-generation arm orthosis. The device, one of the few lightweight wearable devices, restores limb functionality to paralyzed or weakened arms and hands of stroke victims. With...

Celenge Announces Positive Lupus Trial Results

Celenge has announced positive results of its phase 2 clinical trial treating systematic lupus erythematosus (SLE), more commonly referred to as lupus. The drug, C-220, an oral immune-modulatory compound showed greater disease state improvement when compared with...

FDA Requests Endo Pharmaceuticals Opioid Taken off Shelves

The Food and Drug Administration (FDA) has requested Endo Pharmaceuticals to take their opioid painkiller, Opana ER, off the market. The drug has been linked to various disease outbreaks as well has heavy opioid abuse through users who crush and inject the pill. FDA...